<VariationArchive VariationID="56558" VariationName="NM_012434.5(SLC17A5):c.802_816del (p.Ser268_Asn272del)" VariationType="Deletion" Accession="VCV000056558" Version="14" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="8" DateLastUpdated="2024-06-17" DateCreated="2013-07-24" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="71197" VariationID="56558">
      <GeneList>
        <Gene Symbol="SLC17A5" FullName="solute carrier family 17 member 5" GeneID="26503" HGNC_ID="HGNC:10933" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="73593379" stop="73653992" display_start="73593379" display_stop="73653992" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="74303101" stop="74363736" display_start="74303101" display_stop="74363736" Strand="-" />
          </Location>
          <OMIM>604322</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_012434.5(SLC17A5):c.802_816del (p.Ser268_Asn272del)</Name>
      <CanonicalSPDI>NC_000006.12:73635384:ATTTCTTAATGATGAA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="73635385" stop="73635399" display_start="73635385" display_stop="73635399" variantLength="15" positionVCF="73635384" referenceAlleleVCF="GATTTCTTAATGATGA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="74345108" stop="74345122" display_start="74345108" display_stop="74345122" variantLength="15" positionVCF="74345107" referenceAlleleVCF="GATTTCTTAATGATGA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012434.5" sequenceAccession="NM_012434" sequenceVersion="5" change="c.802_816delTCATCATTAAGAAAT" MANESelect="true">
            <Expression>NM_012434.5:c.802_816delTCATCATTAAGAAAT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.74345109_74345123del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.74345109_74345123del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.73635386_73635400del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.73635386_73635400del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008272.1" sequenceAccession="NG_008272" sequenceVersion="1" change="g.23616_23630del">
            <Expression>NG_008272.1:g.23616_23630del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382629.1" sequenceAccession="NM_001382629" sequenceVersion="1" change="c.571_585del">
            <Expression>NM_001382629.1:c.571_585del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369558.1" sequenceAccession="NP_001369558" sequenceVersion="1" change="p.Ser191_Asn195del">
            <Expression>NP_001369558.1:p.Ser191_Asn195del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382630.1" sequenceAccession="NM_001382630" sequenceVersion="1" change="c.802_816del">
            <Expression>NM_001382630.1:c.802_816del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369559.1" sequenceAccession="NP_001369559" sequenceVersion="1" change="p.Ser268_Asn272del">
            <Expression>NP_001369559.1:p.Ser268_Asn272del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382631.1" sequenceAccession="NM_001382631" sequenceVersion="1" change="c.823_837del">
            <Expression>NM_001382631.1:c.823_837del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369560.1" sequenceAccession="NP_001369560" sequenceVersion="1" change="p.Ser275_Asn279del">
            <Expression>NP_001369560.1:p.Ser275_Asn279del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382632.1" sequenceAccession="NM_001382632" sequenceVersion="1" change="c.715_729del">
            <Expression>NM_001382632.1:c.715_729del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369561.1" sequenceAccession="NP_001369561" sequenceVersion="1" change="p.Ser239_Asn243del">
            <Expression>NP_001369561.1:p.Ser239_Asn243del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382633.1" sequenceAccession="NM_001382633" sequenceVersion="1" change="c.802_816del">
            <Expression>NM_001382633.1:c.802_816del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369562.1" sequenceAccession="NP_001369562" sequenceVersion="1" change="p.Ser268_Asn272del">
            <Expression>NP_001369562.1:p.Ser268_Asn272del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382634.1" sequenceAccession="NM_001382634" sequenceVersion="1" change="c.802_816del">
            <Expression>NM_001382634.1:c.802_816del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369563.1" sequenceAccession="NP_001369563" sequenceVersion="1" change="p.Ser268_Asn272del">
            <Expression>NP_001369563.1:p.Ser268_Asn272del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382635.1" sequenceAccession="NM_001382635" sequenceVersion="1" change="c.799_813del">
            <Expression>NM_001382635.1:c.799_813del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369564.1" sequenceAccession="NP_001369564" sequenceVersion="1" change="p.Ser267_Asn271del">
            <Expression>NP_001369564.1:p.Ser267_Asn271del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382636.1" sequenceAccession="NM_001382636" sequenceVersion="1" change="c.484_498del">
            <Expression>NM_001382636.1:c.484_498del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369565.1" sequenceAccession="NP_001369565" sequenceVersion="1" change="p.Ser162_Asn166del">
            <Expression>NP_001369565.1:p.Ser162_Asn166del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012434.5" sequenceAccession="NM_012434" sequenceVersion="5" change="c.802_816del" MANESelect="true">
            <Expression>NM_012434.5:c.802_816del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036566.1" sequenceAccession="NP_036566" sequenceVersion="1" change="p.Ser268_Asn272del">
            <Expression>NP_036566.1:p.Ser268_Asn272del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA263930" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604322.0007" DB="OMIM" />
        <XRef Type="rs" ID="386833994" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_012434.5(SLC17A5):c.802_816del (p.Ser268_Asn272del) AND Sialic acid storage disease, severe infantile type" Accession="RCV000005973" Version="4">
        <ClassifiedConditionList TraitSetID="1582">
          <ClassifiedCondition DB="MedGen" ID="C1096902">Sialic acid storage disease, severe infantile type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012434.5(SLC17A5):c.802_816del (p.Ser268_Asn272del) AND Salla disease" Accession="RCV000049971" Version="14">
        <ClassifiedConditionList TraitSetID="1581">
          <ClassifiedCondition DB="MedGen" ID="C1096903">Salla disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-06" SubmissionCount="7">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012434.5(SLC17A5):c.802_816del (p.Ser268_Asn272del) AND not provided" Accession="RCV000485185" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-06" NumberOfSubmissions="9" NumberOfSubmitters="8" DateCreated="2013-07-24" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10069709</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10581036</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10947946</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12121352</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12359136</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12794688</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15510212</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15516337</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15805149</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2334213</ID>
        </Citation>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-04-26">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1581" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4393" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Salla disease</ElementValue>
                <XRef ID="MONDO:0011449" DB="MONDO" />
                <XRef ID="87074006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sialuria, Finnish type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-acetylneuraminic acid (NANA) storage disease (NSD)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile sialic acid storage disorder (ISSD)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Free Sialic Acid Storage Disorders</ElementValue>
                <XRef ID="NBK1470" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SD</ElementValue>
                <XRef Type="MIM" ID="604369" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Free sialic acid storage disorders (FSASDs) are a spectrum of neurodegenerative disorders resulting from increased lysosomal storage of free sialic acid. Historically, FSASD was divided into separate allelic disorders: Salla disease, intermediate severe Salla disease, and infantile free sialic acid storage disease (ISSD). The mildest type was Salla disease, characterized by normal appearance and absence of neurologic findings at birth, followed by slowly progressive neurologic deterioration resulting in mild-to-moderate psychomotor delays, spasticity, athetosis, and epileptic seizures. Salla disease was named for a municipality in Finnish Lapland where a specific founder variant is relatively prevalent. However, the term Salla has been used in the literature to refer to less severe FSASD. More severe FSASD is historically referred to as ISSD, and is characterized by severe developmental delay, coarse facial features, hepatosplenomegaly, and cardiomegaly; death usually occurs in early childhood.</Attribute>
                <XRef ID="NBK1470" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4754" />
                <XRef ID="4754" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301643</ID>
                <ID Source="BookShelf">NBK1470</ID>
              </Citation>
              <XRef ID="309334" DB="Orphanet" />
              <XRef ID="834" DB="Orphanet" />
              <XRef ID="C1096903" DB="MedGen" />
              <XRef ID="MONDO:0011449" DB="MONDO" />
              <XRef Type="MIM" ID="604369" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1582" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2416" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NANA STORAGE DISEASE</ElementValue>
                <XRef Type="MIM" ID="269920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile Sialic Acid Storage Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile sialic acid storage disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sialuria, infantile form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-Acetylneuraminic acid storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sialic acid storage disease, severe infantile type</ElementValue>
                <XRef ID="Salla+disease/6400" DB="Genetic Alliance" />
                <XRef ID="34566007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Free sialic acid storage disease, infantile form</ElementValue>
                <XRef ID="MONDO:0010027" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ISSD</ElementValue>
                <XRef Type="MIM" ID="269920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NSD</ElementValue>
                <XRef Type="MIM" ID="269920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Free sialic acid storage disorders (FSASDs) are a spectrum of neurodegenerative disorders resulting from increased lysosomal storage of free sialic acid. Historically, FSASD was divided into separate allelic disorders: Salla disease, intermediate severe Salla disease, and infantile free sialic acid storage disease (ISSD). The mildest type was Salla disease, characterized by normal appearance and absence of neurologic findings at birth, followed by slowly progressive neurologic deterioration resulting in mild-to-moderate psychomotor delays, spasticity, athetosis, and epileptic seizures. Salla disease was named for a municipality in Finnish Lapland where a specific founder variant is relatively prevalent. However, the term Salla has been used in the literature to refer to less severe FSASD. More severe FSASD is historically referred to as ISSD, and is characterized by severe developmental delay, coarse facial features, hepatosplenomegaly, and cardiomegaly; death usually occurs in early childhood.</Attribute>
                <XRef ID="NBK1470" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="175" />
                <XRef ID="175" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301643</ID>
                <ID Source="BookShelf">NBK1470</ID>
              </Citation>
              <XRef ID="309324" DB="Orphanet" />
              <XRef ID="834" DB="Orphanet" />
              <XRef ID="C1096902" DB="MedGen" />
              <XRef ID="MONDO:0010027" DB="MONDO" />
              <XRef Type="MIM" ID="269920" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="444308" SubmissionDate="2015-07-22" DateLastUpdated="2015-07-25" DateCreated="2015-07-25">
        <ClinVarSubmissionID localKey="604322.0007_SALLA DISEASE" title="SLC17A5, 15-BP DEL, NT802_SALLA DISEASE" />
        <ClinVarAccession Accession="SCV000240033" DateUpdated="2015-07-25" DateCreated="2015-07-25" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 French Canadian patients with infantile sialic acid storage disease (ISSD; 269920) reported by Lemyre et al. (1999) and in 1 English patient reported by Cameron et al. (1990), Verheijen et al. (1999) found a 15-bp deletion (nucleotides 802-816) resulting in the deletion of amino acids serine, serine, leucine, arginine, and asparagine in the cytosolic loop between transmembrane domains 6 and 7 of the SLC17A5 gene product.</Attribute>
              <Citation>
                <ID Source="PubMed">10069709</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2334213</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10581036</ID>
              </Citation>
              <XRef DB="OMIM" ID="269920" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Biancheri et al. (2002) described 2 Italian brothers with sialic acid storage disease that resembled Salla disease as observed in the Finnish population (SD; 604369) rather than ISSD. Both brothers showed moderate intellectual disability, spastic ataxic syndrome, hypomyelination and cerebellar ataxia on MRI, and lysosomal storage, all typical of Salla disease. In one of the alleles of the younger brother, Biancheri et al. (2002) found the same 15-bp deletion in exon 6 that had been found by Verheijen et al. (1999). No R39C mutation (604322.0001) was found. The older brother had died at the age of 20 years and DNA testing was not performed. The second mutation in the younger brother was presumed to lie in a noncoding area of the gene.</Attribute>
              <Citation>
                <ID Source="PubMed">12121352</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10581036</ID>
              </Citation>
              <XRef DB="OMIM" ID="604369" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Kleta et al. (2003) detected this mutation in compound heterozygous state with an R39C substitution (604322.0001) in a North American patient with Salla disease. Kleta et al. (2003) described this mutation as 801 815del15 and stated that they believed the mutation detected by them was the same as that described by Verheijen et al. (1999).</Attribute>
              <Citation>
                <ID Source="PubMed">12794688</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10581036</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC17A5" />
          </GeneList>
          <Name>SLC17A5, 15-BP DEL, NT802</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">15-BP DEL, NT802</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604322.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">SALLA DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="26155" SubmissionDate="2015-07-22" DateLastUpdated="2015-07-25" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604322.0007_INFANTILE SIALIC ACID STORAGE DISORDER" title="SLC17A5, 15-BP DEL, NT802_INFANTILE SIALIC ACID STORAGE DISORDER" />
        <ClinVarAccession Accession="SCV000026155" DateUpdated="2015-07-25" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 French Canadian patients with infantile sialic acid storage disease (ISSD; 269920) reported by Lemyre et al. (1999) and in 1 English patient reported by Cameron et al. (1990), Verheijen et al. (1999) found a 15-bp deletion (nucleotides 802-816) resulting in the deletion of amino acids serine, serine, leucine, arginine, and asparagine in the cytosolic loop between transmembrane domains 6 and 7 of the SLC17A5 gene product.</Attribute>
              <Citation>
                <ID Source="PubMed">10069709</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2334213</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10581036</ID>
              </Citation>
              <XRef DB="OMIM" ID="269920" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Biancheri et al. (2002) described 2 Italian brothers with sialic acid storage disease that resembled Salla disease as observed in the Finnish population (SD; 604369) rather than ISSD. Both brothers showed moderate intellectual disability, spastic ataxic syndrome, hypomyelination and cerebellar ataxia on MRI, and lysosomal storage, all typical of Salla disease. In one of the alleles of the younger brother, Biancheri et al. (2002) found the same 15-bp deletion in exon 6 that had been found by Verheijen et al. (1999). No R39C mutation (604322.0001) was found. The older brother had died at the age of 20 years and DNA testing was not performed. The second mutation in the younger brother was presumed to lie in a noncoding area of the gene.</Attribute>
              <Citation>
                <ID Source="PubMed">12121352</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10581036</ID>
              </Citation>
              <XRef DB="OMIM" ID="604369" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Kleta et al. (2003) detected this mutation in compound heterozygous state with an R39C substitution (604322.0001) in a North American patient with Salla disease. Kleta et al. (2003) described this mutation as 801 815del15 and stated that they believed the mutation detected by them was the same as that described by Verheijen et al. (1999).</Attribute>
              <Citation>
                <ID Source="PubMed">12794688</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10581036</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC17A5" />
          </GeneList>
          <Name>SLC17A5, 15-BP DEL, NT802</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">15-BP DEL, NT802</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604322.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INFANTILE SIALIC ACID STORAGE DISORDER</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1365693" SubmissionDate="2018-01-25" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="NM_012434.4:c.802_816del15|MedGen:C1096903" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000699341" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12359136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15516337</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15805149</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10947946</ID>
          </Citation>
          <Comment>Variant summary: The SLC17A5 c.802_816del15 (p.Ser268_Asn272del) variant causes an in-frame deletion in the cytosolic loop between TM domains 6 and 7 (Aula_2000). This variant was found in 2/119968 control chromosomes at a frequency of 0.0000167, which does not exceed the estimated maximal expected allele frequency of a pathogenic SLC17A5 variant (0.0023717). Multiple publications cite the variant in affected homozygous and compound heterozygous individuals diagnosed with ISSD. Functional studies found that due to this variant the ISSD polypeptide is mainly constrained to the Golgi compartment with limited presence in the lysosomes (Aula_2002) and also that it abrogates the transport activity of sialin (Wreden_2016) In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic/likely pathogenic. Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC17A5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="386833994" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012434.4:c.802_816del15</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1096903" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2868787" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_012434.5:c.802_816delTCATCATTAAGAAAT|Salla disease" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001453512" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012434.5:c.802_816delTCATCATTAAGAAAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Salla disease</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3970992" SubmissionDate="2021-11-24" DateLastUpdated="2021-11-29" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="NM_012434.5:c.802_816del|OMIM:604369" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002027575" DateUpdated="2021-11-29" DateCreated="2021-11-29" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC17A5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012434.5:c.802_816del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604369" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10716879</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1103859" SubmissionDate="2023-05-03" DateLastUpdated="2023-05-06" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDXSV:269839" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000568752" DateUpdated="2023-05-06" DateCreated="2017-04-27" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 5 amino acids in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 15516337, 12121352, 15510212, 12359136, 21781115, 12794688, 10069709, 15805149, 10947946, 2334213, 16170568, 10581036)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC17A5" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:737942</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012434.4:c.802_816del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_182_20230503054203</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2292144" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2020-02-28">
        <ClinVarSubmissionID localKey="NM_012434.5:c.802_816del|OMIM:604369" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001163088" DateUpdated="2024-06-17" DateCreated="2020-02-28" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012434.5:c.802_816del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604369" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BG_GA_2018_SNVs_INDELS</SubmissionName>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="131769" SubmissionDate="2013-05-19" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="FINDIS282" />
        <ClinVarAccession Accession="SCV000082380" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)" OrgID="500116" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>probable-pathogenic</GermlineClassification>
          <Comment Type="ConvertedByNCBI">Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">12121352</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012434.4:c.802_816del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Salla disease</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="604369" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">FinDis database variant: This variant was not found or characterized by our laboratory, data were collected from public sources: see reference</Comment>
        <SubmissionNameList>
          <SubmissionName>FinDis_mutations</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2363653" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="2782252|MedGen:C1096903" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001198532" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10581036</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12794688</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15805149</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12359136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15510212</ID>
          </Citation>
          <Comment>This variant, c.802_816del, results in the deletion of 5 amino acid(s) of the SLC17A5 protein (p.Ser268_Asn272del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs386833994, gnomAD 0.006%). This variant has been observed in individual(s) with severe infantile sialic acid storage disease (PMID: 10581036, 12794688, 15805149). This variant is also known as 801-815del, SSLRN deletion, or "the ISSD deletion". ClinVar contains an entry for this variant (Variation ID: 56558). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects SLC17A5 function (PMID: 12359136, 15510212). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC17A5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.74345108_74345122del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1096903" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1103859" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2363653" TraitType="Disease" MappingType="XRef" MappingValue="C1096903" MappingRef="MedGen">
        <MedGen CUI="C1096903" Name="Salla disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3970992" TraitType="Disease" MappingType="XRef" MappingValue="604369" MappingRef="OMIM">
        <MedGen CUI="C1096903" Name="Salla disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="26155" TraitType="Disease" MappingType="Name" MappingValue="INFANTILE SIALIC ACID STORAGE DISORDER" MappingRef="Preferred">
        <MedGen CUI="C1096902" Name="Sialic acid storage disease, severe infantile type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1365693" TraitType="Disease" MappingType="XRef" MappingValue="C1096903" MappingRef="MedGen">
        <MedGen CUI="C1096903" Name="Salla disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="131769" TraitType="Disease" MappingType="Name" MappingValue="Salla disease" MappingRef="Preferred">
        <MedGen CUI="C1096903" Name="Salla disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="444308" TraitType="Disease" MappingType="Name" MappingValue="SALLA DISEASE" MappingRef="Alternate">
        <MedGen CUI="C1096903" Name="Salla disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2868787" TraitType="Disease" MappingType="Name" MappingValue="Salla disease" MappingRef="Preferred">
        <MedGen CUI="C1096903" Name="Salla disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2292144" TraitType="Disease" MappingType="XRef" MappingValue="604369" MappingRef="OMIM">
        <MedGen CUI="C1096903" Name="Salla disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

